Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent
1995-06-07
1999-04-06
Knode, Marian C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
4242041, 4242321, 435 691, 435 693, 4351723, 4352351, 4352401, 4353201, 536 231, 536 2372, 935 65, 935 9, 935 32, 935 57, A61K 3912, C12P 2106, C12N 1500, C07H 2102
Patent
active
058914420
ABSTRACT:
What is described is a recombinant poxvirus, such as fowlpox virus, containing foreign DNA from infectious bursal disease virus. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine.
REFERENCES:
Jagadish, M. et al 1988, J. Virol. vol. 62, No. 3, pp. 1084-1087.
Jagadish, M. et al 1991, Virology vol. 184, pp. 805-807.
Azad, A. et al 1986, Virology vol. 149, pp. 190-198.
Fahey, K. et al 1989, J. Gen. Virology, vol. 70, pp. 1473-1481.
Azad, A. et al., 1987, Virology-vol. 161, pp. 145-152.
Bayliss, C. et al., 1990, J. Gen. Virol., vol. 71, pp. 1303-1312.
Taylor, J. et al, 1988, Vaccine, vol. 6, pp. 504-508.
Taylor, J. et al, 1990, J. of Virol., pp. 1441-1450.
Kibenge, F. et al, 1988, J. Gen. Virol, vol. 69, pp. 1757-1775.
Gettig Russell
Paoletti Enzo
Taylor Jill
Knode Marian C.
Salimi Ali R.
Virogenetics Corporation
LandOfFree
Infectious bursal disease virus recombination poxvirus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Infectious bursal disease virus recombination poxvirus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Infectious bursal disease virus recombination poxvirus vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1368697